The Chronic Lymphocytic Leukemia Treatment Market Grows Incredibly; Confirms Mrfr Unleashing Industry Prognostications Up To 2023

 Market Scenario

As per the data experts at Market Research Future (MRFR), the chronic lymphocytic leukemia treatment market was worth USD 7.9 Billion in 2017. Additionally, the market is expected to expand at a growth rate of 19% over the forecast period (2018-2023).

Market Drivers and Key Challenges

Chronic lymphocytic leukemia is considered to be one of the most common types of leukemia in adults. This type of cancer involves the development of lymphocytes, which are white blood cells, within the bone marrow. The lymphocytic leukemia cells are generally present in the lymph nodes along with various other tissues. There are two primary types of chronic lymphocytic leukemia, wherein one grows slowly, and the other is considered fatal. In general, one does not experience any symptoms due to chronic lymphocytic leukemia for a long period. However, the symptoms usually noted include fatigue, easy bruising, and swollen lymph nodes.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6900 

Generally, the most popular form of treatment for CLL is chemotherapy, whereas stem-cell transplant is for rare cases. An article published by Apollo Hospitals states that in India, roughly one million cases of chronic lymphocytic leukemia are diagnosed annually. As per the cancer statistics, 1 in every 155 men and 1 in every 260 women get affected with CLL in their lifetime, in the United Kingdom (U.K). The boost in cancer cases around the world, innovations in drug therapy, quick regulatory approval processes, and vigorous pipeline of drugs for chronic lymphocytic leukemia treatment are additional factors substantiating the growth of the chronic lymphocytic leukemia market.

Having said that, the stunted level of awareness with regard to symptoms is expected to retard the market growth in the forthcoming years. However, growing research & development activities coupled with continuous technological developments in the field is presumed to augment the market growth to a large extent.

Market Segmentation

The global chronic lymphocytic leukemia treatment market has been segmented on the basis of type, treatment, and end user.

The market, in terms of the type, has been considered for indolent CLL and aggressive CLL.

The market, treatment-wise, can be broken down into chemotherapy, targeted drug therapy, immunotherapy, and bone marrow transplant.

The end users in the global market are hospitals & clinics, diagnostic laboratories, research institutes, and others.

Prominent Players

The prominent vendors within the worldwide chronic lymphocytic leukemia treatment market include Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca, Genmab A/S, TG Therapeutics, Inc., Ziopharm Oncology, F. Hoffmann-La Roche Ltd, AbbVie Inc., Genentech, Inc., Gilead, Genzyme Corporation, ONO PHARMACEUTICAL CO., LTD., GlaxoSmithKline plc, CELGENE CORPORATION, Inc., Johnson & Johnson Services, Inc., and others.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/chronic-lymphocytic-leukemia-treatment-market-6900

3D Printing Medical Devices Market Up To 2023: Top Companies, Growth Factors Details And Regional Overview By Types & Application

 3D Printing Medical Devices Market Overview

As per Market Research Future (MRFR) analysis, the global 3D printing medical devices market is projected to grow at a CAGR of 18% from 2018 to 2023 (forecast period). 

3D printing plays a vital role in the development of medical and dental devices. 3D printing is the most commonly used medical device and, due to its versatility, can also be used for other items, including food, household items, and automotive parts. The 3D printing technology is used to treat various types of therapies, such as hip and jaw titanium replacements, limb prosthetics and plastic tracheal splints, etc. Due to advanced technology and easy use of devices, many doctors prefer 3D printing devices before surgeries of any organ part that may minimize error. A computer-aided design drawing or a magnetic resonance image is a 3D object created from a digital 3D image. The 3D object is formed by creating successive layers of material in which each layer is connected to the previous layer until the object is complete. Various types of materials are used to create a 3D image. 

Get a FREE Sample with Complete TOC @ https://www.marketresearchfuture.com/sample_request/6830

3D Printing Medical Devices Market Dynamics 

The global market for 3D printing medical devices is expected to expand due to growing government spending in the healthcare sector, rising technological developments in 3D printing, easy production of medical devices, and the growing use of 3D printing devices in the healthcare sector. 3D printing plays a crucial role in the medical and dental manufacturing market. This is a very cost-effective and preferred choice for medical device manufacturers for all kinds of medical devices such as prostheses, hearing aids, custom knee, and hip implants. The 3D printing medical devices are expected to show substantial growth during the forecast period due to various technological developments in this field. In addition, a variety of other factors, such as investment in R&D, rapidly growing consumer base, increasing the reach of biomedical applications, have driven market growth. 

However, some aspects that may hinder future market growth are unfavorable reimbursement policies, high printer costs, biocompatibility issues for 3D printed medical devices, and limited technical knowledge in medical devices. 

3D Printing Medical Devices Market Segmentation 

The global market for 3D printing medical devices has been segmented into types, components, technology, application, and end-users. 

Based on types, the global market for 3D printing medical devices is classified into the segments of surgical guides, prosthetics & implants, surgical instruments, and tissue engineering products. The Surgical Guide is predicted to hold the largest share of the 3D printing market for medical devices in the forecast period. The 3D printing surgical guide is part of operation preparation and offers precise restoration of the implant. The demand for a surgical guide is therefore growing which is a significant factor driving the growth of this market segment. 

Based on components, the global market for 3D printing medical devices is divided into materials software & services, 3D printer, and 3D bioprinter. Software & services are projected to register for the largest market share in 3D medical device printing in the forecast period. Growing development of software solutions for the production of high-quality 3D-printed medical products is a primary driver of the growth of the services and software segment. 

On the basis of technology, the market for 3D printing medical device is segmented into 3D printing, droplet deposition, laser beam melting, photopolymerization, laminated object manufacturing (LOM), electron beam melting (EBM), polyjet technology and others. Photopolymerization is projected to maintain the largest market share in the 3D printing medical device.  

Depending on the application, the global 3D printing medical device market is segmented into external wearable devices, implants and tissue engineering, and clinical trial devices. The external wearable devices segment retains the largest share of the 3D printing medical devices market in the forecast period. 

Depending on end-users, the global 3D printing medical device market is categorized into hospitals, medical and surgical centers, pharmaceutical and biotech firms, academic institutions, and contract research organizations. The segment of medical and surgical centers accounts for the largest share of the 3D printing medical devices market due to an increasingly growing patient population and reduced risk of surgery and infection. 

3D Printing Medical Devices Market Regional Analysis 

The market has been segmented by area across the Americas, Europe, the Asia Pacific and the Middle East and Africa. The market for 3D printing medical device in the Americas has been further broken down into North America and South America, with the North American market split into the USA and Canada. The European market for 3D printing medical devices has been segmented into Western Europe and Eastern Europe. Western Europe has also been listed as Germany, France, the United Kingdom, Italy, Spain, and the rest of Western Europe. The market for 3D printing medical devices in the Asia Pacific has been segmented into China, Japan, India, Australia, South Korea, and the rest of the Asia Pacific. The market for biomaterials in the Middle East and Africa has been segmented into the Middle East and Africa. 

North America dominates the market for global 3D printing medical devices over the forecast period. The largest share is due to a growing demand for organ transplantation across the region. Some of the aspects responsible for market growth in this region are attributed to increased government spending to develop advancements in 3D printing technologies and applications. 

The second-largest 3D printing medical devices market is projected to be the European market. Market growth in this region can be ascribed to government funding and support for the healthcare sector, combined with increased research and development. In addition, an increasing number of surgeries due to changing lifestyles are leading to the growth of the market in the region. 

The Asia Pacific is predicted to be the fastest-growing 3D printing medical device market in the forecast period due to the rising prevalence of chronic diseases, increasing investment in healthcare, growing geriatric population, and the proliferation of market players in the region. 

The market in the Middle East and Africa is projected to register for the smallest share of the market for global 3D printing medical devices due to underdeveloped healthcare, lack of technological expertise and inadequate medical facilities. 

3D Printing Medical Devices Market Key Players  

Some of the prominent players in the market for 3D printing medical devices are SLM Solutions Group AG, 3D Systems Corporations, Stratasys Ltd., EnvisionTEC, Arcam AB, Organovo Holdings, Inc., Materialise NV, Oxford Performance Materials, Inc., Bio3D Technologies, Prodways Group, Cyfuse Medical K.K.EOS GmbHConcept, Laser GmbH, 3T RPD Ltd, Renishaw plc.

Obtain Premium Research Report Details @ https://www.marketresearchfuture.com/reports/3d-printing-medical-devices-market-6830 

The Controlled Release Drug Delivery Market Grows Incredibly; Confirms Mrfr Unleashing Industry Prognostications Up To 2023

 Controlled Release Drug Delivery Market Highlights

Controlled release drug delivery provides drug-encapsulating devices from which therapeutic molecules are released at a controlled rate for a period of time, that can be adjusted from days to months. These products are applicable for all age group, but it is highly preferred for the old age and pediatric population to reduce to dose and administer a uniform amount of drug. The key factors responsible for driving this market are growing R&D in the healthcare industry, increasing deaths due to overdose, and rising health-related problems due to the high dose.
Controlled release drug delivery maintains the plasma concentration for various treatment for a period of time. There are different innovative techniques by which the drug can be delivered in controlled amounts. The various ways could be oral form, through nasal, injection and many more, but the oral route is more preferred compared to other form.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6794 

The controlled release drug delivery market was estimated USD 31.96 billion in 2017 and expected to reach USD 70.15 billion by 2023 at a CAGR of 14.0% during the forecast period. However, factors such as less awareness and higher cost per dosage may hinder the market growth during the forecast period.

Segmentation
The global controlled release drug delivery market is segmented on the basis of route of administration, release mechanism, products, and end user.
By route of administration the market is segmented into oral, injectable, ocular, nasal, topical and implantable. The injectable is sub-segmented into targeted delivery, transmucosal, and transdermal. On the basis of release mechanism, the market is segmented into polymer-based drug delivery systems, micro-reservoir partition-controlled drug delivery systems, feedback-regulated drug delivery systems, activation modulated drug delivery systems, and chemically activated controlled drug delivery systems. The activation modulated drug delivery systems are sub-segmented into osmotic pressure activated drug delivery, hydrodynamic pressure activated drug delivery, vapor pressure activated drug delivery, mechanically activated drug, magnetically activated drug. The chemically activated controlled drug delivery systems are sub-segmented into pH-activated drug delivery, hydrolysis activated drug delivery, enzyme activated drug delivery.
On the basis of products, the market is segmented into metered dose inhalers, needle-free injectors, auto-injectors, nasal sprays, transdermal patches, nebulizers, infusion pumps, drug-eluting stents, sustained release, and ocular implants. By end user, the market is segmented into hospital and clinics, personal use, research centers, and others.


Regional Analysis
The Americas is expected to lead the global controlled release drug delivery market owing to the increasing government support for the development of controlled release drug delivery and rising investments in research & development are enhancing the market growth in the region. The increasing prevalence of chronic diseases such as diabetes, cancer, respiratory diseases, Alzheimer’s, etc. are also contributing the market growth. According to the National Cancer Institute, it is estimated that 1,735,350 people will be diagnosed with cancer and 609,640 adults will die in the US in 2018. The increasing number of a cancer patient may boost the market growth in this region.
Europe holds the second largest market for controlled release drug delivery during the forecast period. The rising number of New Drug Application (NDA) and Abbreviated new drug application (ANDA) applications in the region is also supporting and playing a significant role in the growth of the regional market. Apart from this, the rising geriatric population in Europe enhances the market. According to the Office for National Statistics 2017, the UK population is getting older with 18% aged 65 and above and 2.4% aged 85 years. The increasing in aging may boost the controlled release drug delivery market.
Asia-Pacific was expected to be the fastest growing region for the global controlled release drug delivery market. The market is expected to observe high growth owing to the increasing support by government and private funding agencies for the development of healthcare products and increasing expansion in pharmaceutical industries by India, Japan and China support the market growth in this region.
The Middle East and Africa holds the lowest share for controlled release drug delivery market due to the less per capita income and fewer healthcare facilities. However, the growing campaigns for creating awareness about healthcare facilities may increase the market growth in the Middle East and Africa.

Key Players
Some of the key players in the global controlled release drug delivery market are Depomed, Inc. (US), Coating Place, Inc.(US), Corium International Inc.(US), Alza Corporation (Johnson & Johnson)(US), Pfizer Inc.(US), SKY Pharmaceuticals Pvt. Ltd.(China), AstraZeneca (US),Biogen (US), GlaxoSmithKline (UK), Novartis (UK), Allergan (‎Ireland), Collegium Pharmaceutical(US), and others.

FOR MORE DETAILS –  https://www.marketresearchfuture.com/reports/controlled-release-drug-delivery-market-6794 

The Biologics Safety Testing Market Grows Incredibly; Confirms Mrfr Unleashing Industry Prognostications Up To 2023

 

Market Highlights:

The global biologics safety testing market held a value of USD 2.79 billion in the year 2017 and is expected to register a CAGR of 13.6% during the forecast period. Biologics safety testing is required for all biopharmaceutical products and vaccines to ensure the product is safe and free of contaminants.

Growing pharmaceutical and biotech industry and increasing demand for biological products are expected to drive the growth of the market. However, stringent government regulations for the approval of biosimilars and high cost of drug development are likely to hamper the market growth over the forecast period.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6800 

Regional Analysis:

Geographically, the Americas is expected to dominate the global market owing to the presence of well-established players and rising demand for biological products. Europe is expected to hold the second largest position in the global market owing to the growing pharma and biotech industry. Asia-Pacific is expected to be the fastest growing market owing to the increasing demand for biologics products. Furthermore, the Middle East and Africa region is expected to account for the least market share in the global market.

Segmentation:

The global biologics safety testing market has been segmented into product, test type, and application.

Based on product, the market is segmented into kits & reagents, services, and instruments. The kits & reagents segment is expected to account for the largest share segment of the global market in 2017.

Based on test type, the market is segmented into sterility tests, endotoxin tests, cell line authentication and characterization tests, residual host contamination detection tests, adventitious agent detection tests, bioburden tests, and others.

Based on application, market segmented into vaccine and therapeutics development, blood and blood-related products testing, cellular and gene therapy, tissue and tissue-related products testing, and stem cell research.

Key Players:

Some of the prominent players in the global biologics safety testing market are Merck KGaA, Charles River Laboratories, Sartorius AG, Lonza Group Ltd., SGS S.A., Thermo Fisher Scientific Inc, Wuxi Apptec, Cytovance Biologics, Inc., Avance Biosciences Inc., and Eurofins Scientific.

FOR MORE DETAILS –  https://www.marketresearchfuture.com/reports/biologics-safety-testing-market-6800

Worldwide Diagnostic Imaging Market Ready To Set Outstanding Growth From 2020 To 2023

 

Market Highlights:

Diagnostic imaging helps to understand the functioning of body parts and create visual representation of interior of the body and provides support in detection of medical disorder. The continues increase in geriatric population, increasing prevalence of chronic diseases, and  technological advancements are the major factors driving the growth of the globaldiagnostic imaging market. Additionally, increasing investment in R&D and aggressive strategies adopted by the major players, such as new product launches along with merger and acquisitions, are contributing to the growth of the market. For instance, in March 2017, General Electric Company announced the acquisition of Monica healthcare  for undisclosed amount, with this transaction the company will gain control over 1000 sites of Monica healthcare across Europe, Asia and north America .

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6683 

The high costs associated with diagnostic imaging devices, unfavorable reimbursement policies and scarcity of technicians are likely to hinder market growth during the forecast period.

Regional Analysis:

The market in the Americas is expected to dominate the global diagnostic imaging market during the forecast period due to the increasing number of patients suffering from chronic diseases,  surge in geriatric population, rising prevalence of cancer, and well-established healthcare system

The European market is expected to hold the second position in the global diagnostic imaging market owing to the government support and favorable regulatory policies, increasing medical and diagnostic centers, and increasing healthcare expenditure. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing population and subsequently increasing chronic diseases, rising investment in healthcare and increase in disposable income. The market in the Middle East & Africa is likely to hold  the smallest share of the global diagnostic imaging market.

Segmentation:

The global diagnostic imaging market has been segmented on the basis of product, source, and application.

Based on  product type, the market has been divided into x-ray equipment, ultrasound imaging systems, nuclear imaging systems, magnetic resonance imaging (MRI), computed tomography (CT) scanners, and other products

The market, by application, has been segmented into gynecology, oncology, orthopedics, cardiology, gastroenterology, neurology, and other applications

The end-user segment has been further divided into hospitals and clinics, diagnostic centers, research institutes, and others.     

Key Players:

Some of the key players in the global diagnostic imaging market are Siemens Healthcare Private Limited, Koninklijke Philips N.V.,CANON MEDICAL SYSTEMS CORPORATION, Shimadzu Corporation, Carestream Health,Esoate SpA, GE Healthcare, Toshiba Medical Systems Corporation,FUJIFILM Holdings Corporation, Hitachi Medical Systems, and Hologic Inc.

FOR MORE DETAILS –  https://www.marketresearchfuture.com/reports/diagnostic-imaging-market

The Abetalipoproteinemia Monitoring Systems Market Grows Incredibly; Confirms Mrfr Unleashing Industry Prognostications Up To 2023

 

Abetalipoproteinemia Monitoring Systems Market – Overview:

The abetalipoproteinemia monitoring systems market is profiting as awareness regarding physiological disorders is rising and cases getting registered more and more every day. The disease is caused by a mutation in microsomal triglyceride transfer protein. It can perturb the gastrointestinal system, eyes, nervous system, and blood circulation. The disease further unsettles the normal absorption process of fat and fat-soluble vitamins from food. The global abetalipoproteinemia monitoring systems market is expecting an impressive 9.8% CAGR during the forecast period (2018-2023).

In the process, the market can also scale its valuation to USD 147 million by 2023, claims Market Research Future (MRFR). The report further encompasses market drivers such as supportive treatment that backs the treatment properly, along with, well-structured diagnostic treatment facility.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6683 

On reverso, the disease is so rare that a substantial patient pool to support the abetalipoproteinemia monitoring systems market growth seems to be a far-fetched plan. Furthermore, vision loss is a problem that can deter many from availing the necessary treatment. However, gene therapy treatment is advancing significantly and can steer away from the abetalipoproteinemia monitoring systems market from sluggish growth in the coming years.       

Abetalipoproteinemia Monitoring Systems Market – Competition Insight:

The abetalipoproteinemia monitoring systems market is banking mostly on the strategies implemented by prominent companies with significant market impact. These tactics, not only help in individual sustenance but assists in expansion for the market as a whole. Merger, acquisition, collaboration, product launch, and other methods are few examples of such extensive procedures that are bound to impact the market.

Major market influencers of the abetalipoproteinemia monitoring systems market are Lonza, Piramal Pharma Solutions, Abbott Laboratories, Koninklijke DSM N.V., and Barrington Nutritionals.

Abetalipoproteinemia Monitoring Systems Market – Segmentation:

The global abetalipoproteinemia monitoring systems market can be segmented by diagnosis, blood testing treatment, and end-user.

Diagnosis-wise, the abetalipoproteinemia monitoring systems market includes molecular genetic testing and blood testing. Molecular genetic testing has the maximum market share and is expected to grow further with the fastest CAGR during the forecast period.  

Based on blood testing treatment, the abetalipoproteinemia monitoring systems market consists fat-soluble vitamins supplementation and others. Fat-soluble vitamins supplementation is taking charge of the segment.

Based on end-user, the abetalipoproteinemia monitoring systems market comprises hospitals & clinics, diagnostics lab, and others. Hospitals & clinics segment fetch in the maximum revenue.

Abetalipoproteinemia Monitoring Systems Market – Regional Analysis:

The Americas, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA) are prominent regions on the basis of which the report on abetalipoproteinemia monitoring systems market has been made.

The Americas can be further segmented into North and South America. North America includes the U.S. and Canada, two countries with superlative medical facilities. Medical infrastructure and reimbursement policies are quite supportive. However, the disease is so rare that a substantial growth based is highly unlikely. The region can expect moderate growth during the forecast period.

Europe shares similar features with the market of the Americas. Its research and development facilities are quite astounding and, like the Americas, Europe too has several companies based out of the region to support the market expansion.

The APAC is the new booming market. Medical tourism is gaining popularity and infrastructure in many countries are getting revamped owing to which the region can record significant growth. Furthermore, just like the MEA market, the region has several countries with huge population suffering from malnutrition which is also a major trigger for abetalipoproteinemia.

Industry Updates:

March 21, 2018: Designed for seniors, TruSense, a smart home monitoring solution, has recently announced that it has added its first-ever smart personal emergency response pendant which combine GPS with notification when it is not being worn, thus extending protection even when outside the home. TruSense GPS Smart Pendant works in combination with TruSense Home. The combination offers customized alerts whenever the pendant is not being worn, thereby eradicating all the false sense of security created.

FOR MORE DETAILS –  https://www.marketresearchfuture.com/reports/abetalipoproteinemia-monitoring-systems-market-6683 

Medical Pendant Market Sparkling Growth Worldwide Forecasts By 2023

 

Medical Pendant Market – Overview:

The Global Medical Pendant Market is presumed to garner USD 149.01 million during the forecast period (2017-2023). The market is anticipated to register 7% CAGR owing to the technological advancements, asserts Market Research Future (MRFR). Medical pendant is referred to as a wireless device which is designed to alert the healthcare professionals about the occurrence of any hazard or emergency which require immediate attention. A medical pendant system is usually installed on the ceiling of a hospital with a strong body system which is built of supporting rods and stainless-steel extensions. They are compact with customizable configurations to fulfill the requirements of healthcare centers and hospitals.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6681 The growing need for low-risk and safe workspace for medical workforce is fueling the global medical pendant market during the assessment period. Technological advancements such as button-press enabled medical pendants which facilitate the system’s arm movement are further fostering the global market. Devices with multifaceted designs and ultra-flexible configurations are commercially available which focuses on fulfilling the requirements of the healthcare specialties. Such devices are expected to gain traction across the globe which is further likely to trigger the market growth in the coming years. Moreover, growing demand for medical pendants in the ICU and operating theatres are likely to spur the market growth.

On the flip side, high cost of medical pendants coupled with the lack of professional technicians are anticipated to impede the market growth in the coming years.

Medical Pendant Market – Competitive Dashboard:

The noteworthy players operating the global medical pendant market are MEDIMAXKOREA, Starkstrom, Tedisel Medical, Megasan Medikal, Surgiris, Brandon Medical Co. Ltd., BeaconMedæs, Skytron LLC, Elektra Hellas S.A., and Ondal Medical Systems GmbH.

Medical Pendant Market: Segmental Analysis:

The global medical pendant market has been segmented on the basis of product, application, and region.By mode of product, the global medical pendant market has been segmented into fixed pendants, fixed retractable pendants, single arm movable pendants, double & multi-arm movable pendants, and accessories. Among these, the fixed pendants hold the largest market share, whereas the single arm moveable pendants account for the fastest growing segment.

By mode of application, the global medical pendant market has been segmented into hospital, clinics and others. The hospital segment is further sub-segmented into intensive care unit (ICU), operating theatre (OT) & recovery room (RR), and emergency room (ER). Among these, the clinics segment is expected to be the fastest growing segment.

Medical Pendant Market – Regional Insights:

Geographically, the global medical pendant market span across major four regions, namely Europe, America, Asia Pacific, and the Middle East & Africa.

The North American region in the Americas is presumed to dominate the global medical pendant market in terms of revenue owing to the presence of world class healthcare infrastructure, advanced facilities, top notch healthcare practices, and strict mandates from the regulating authorities.

The Asia Pacific region is anticipated to account for the fastest growth owing to the rapid growth in the healthcare infrastructure, increased spending, and government initiatives and focus on better healthcare practices owing to the rising medical tourism industry.Industry Updates:

March 21, 2018: Designed for seniors, TruSense, a smart home monitoring solution, has recently announced that it has added its first-ever smart personal emergency response pendant which combine GPS with notification when it is not being worn, thus extending protection even when outside the home. TruSense GPS Smart Pendant works in combination with TruSense Home. The combination offers customized alerts whenever the pendant is not being worn, thereby eradicating all the false sense of security created.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/medical-pendant-market-6681